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Background. Adolescents living with HIV (ALHIV) are challenged to adhere to antiretroviral therapy (ART) and achieve and
maintain virologic suppression. Group-based adherence support interventions, such as adherence clubs, have been shown to
improve long-term adherence in ART patients. +e teen club intervention was introduced in 2010 in Namibia to improve
treatment outcomes for ALHIV by providing adherence support in a peer-group environment. Adolescents who have completed
the full HIV disclosure process can voluntarily join the teen clubs. +e current study compared treatment outcomes of ALHIV
receiving ART at a specialized paediatric HIV clinic between 1 July 2015 and 30 June 2017 in Windhoek, Namibia. Methods. A
retrospective cohort analysis was conducted on routine patient data extracted from the electronic Patient Monitoring System,
individual Patient Care Booklets, and teen club attendance registers. A sample of 385 adolescents were analysed: 78 in teen clubs
and 307 in standard care. Virologic suppression was determined at 6, 12, and 18 months from study start date, and compared by
model of care, age, sex, disclosure status, and ART regimen. Comparisons between adolescents in teen clubs and those receiving
standard care were performed using the chi-square test, and risk ratios were calculated to analyze differences in ART adherence
and virologic suppression. Results. +e average clinician-measured ARTadherence was 89% good, 6% fair, and 5% poor amongst
all adolescents, with no difference between teen club members and adolescents in standard care (p � 0.277) at 3 months. Virologic
suppression over the 2-year observation period was 87% (68% fully suppressed <40 copies/ml and 19% suppressed between
40–999 copies/ml), with no difference between teen club members and those in standard care. However, there were statistically
significant differences in virologic suppression levels between the younger (10–14 years) adolescents and older (15–19 years)
adolescents at 6 months (p � 0.015) and at 12 months (p � 0.021) and between adolescents on first-line and second-line ART
regimen at 6 months (p � 0.012), 12 months (p � 0.004), and 18 months (p � 0.005). Conclusion. +e teen club model delivering
psychosocial support only did not improve adherence and virologic suppression levels for adolescents in a specialized paediatric
ARTclinic, neither were they inferior to standard care. Considering the limitations of this study, teen clubs may still hold potential
for improving adherence and virologic suppression levels for older adolescents, and more robust research on adherence in-
terventions for adolescents with higher methodological quality is required.
1. Introduction
Due to the successes in prevention of mother-to-child
transmission (PMTCT) programs worldwide and advances
in paediatric HIV treatment, children with HIV are sur-
viving to reach adolescence [1]. +e World Health Orga-
nization defines adolescents as children or young adults
between 10 and 19 years of age [2]. Worldwide in 2018, an
estimated 1.6 million adolescents between 10 and 19 years
were living with HIV, with nearly 85% living in sub-Saharan
Africa [3, 4]. In most sub-Saharan Africa countries, public
health facilities are ill-equipped to give guidance and support
for adolescents living with HIV (ALHIV) to remain engaged
in care and adhere to medication regimens [5]. In 2019
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alone, there were 460,000 newly infected young people
between the ages of 10 to 24 years, of whom 170,000 were
adolescents between 10 to 19 years [6].
Poor ART adherence increases the risk of viral drug
resistance, limits treatment efficacy, leading to disease
progression, and reduces future therapeutic options as well
as increasing the risk of transmission due to unsuppressed
viral replication [7]. Although reported ART adherence is
high globally (>95%), concerns have been raised about
waning adherence over time including loss of patients from
HIV programs when scaling up [8]. Evidence-based inter-
ventions to address adherence challenges for people on ART
include individual and group adherence counselling,
mHealth platforms, community and home-based strategies,
pharmacist counselling and monitoring, task-shifting,
medication fast-tracking, nutrition support, and provision of
disability grants [9]. For ALHIV, individual counselling,
group counselling, and peer support, such as in teen clubs,
have been some of the most common interventions in
Namibia.
Namibia has adopted the Joint United Nations Pro-
gramme on HIV and AIDS’ (UNAIDS) fast track goals to
achieve HIV epidemic control by 2030. +e fast track goals
are aimed at ensuring that 95% of PLHIV are identified; 95%
of those identified are effectively linked and retained on
ART; and 95% of these achieve virologic suppression [10].
Adolescents living with HIV have unique needs and are
notably underserved globally and in national responses,
which negatively affects their access to ART and results in
poor ART adherence and inferior treatment outcomes such
as achieving and maintaining virologic suppression [11]. In
Namibia, infants, children, and younger adolescents (0–14
years) reportedly had only 63% viral load suppression, and
young people (older adolescents and young adults, 15–24
years old) had 60.5%, which is well below the national av-
erage suppression levels for adults on ART at 80.5% [12].
According to WHO, a maintained viral load of <1000
ribonucleic acid (RNA) copies per ml of plasma is con-
sidered evident of virologic suppression [13]. According to
the 2019 Namibia National Guidelines for Antiretroviral
Treatment, virologic status is classified into three categories,
namely, fully suppressed (<40 copies/ml), suppressed
(40–999 copies/ml), and unsuppressed (≥1000 copies/ml).
+e aim of this classification is for earlier identification of
patients having suboptimal responses to therapy, whose
immunologic and clinical responses may not have deteri-
orated at this stage, but persistently have viral loads of above
40 copies/ml. +ese patients undergo different clinical
management, which includes intensive adherence counsel-
ling and support to achieve full suppression and avoid
treatment failure that may necessitate switching to a second-
line ART regimen [14].
A teen club intervention was established in 2010 at a
paediatric HIV clinic, inWindhoek, to address unique needs
of adolescents on HIV treatment [15]. +e teen club aims to
improve ART adherence through, among other activities,
psychosocial support, HIV counselling, and health educa-
tion. In 2010, teen club interventions were introduced at
health facilities in Malawi to provide ALHIV on ART with
dedicated clinic time, peer mentorship, sexual and repro-
ductive health education, ARTrefill and support for positive
living, and treatment adherence. An evaluation of the
program in 2015 found that ALHIV with no teen club ex-
posure were less likely to be retained than those with teen
club exposure (adjusted odds ratio (aOR) 0.27; 95% CI 0.16,
0.45). ALHIV aged 15–19 years were more likely to have
attrition from care than those aged 10–14 years (aOR 2.14;
95% CI 1.12, 4.11) [16]. Another evaluation in Malawi of a
similar teen club intervention reported in 2019 on adherence
levels between younger and older adolescents and male and
female adolescents found that older adolescence were as-
sociated with higher odds of optimal adherence compared to
younger adolescents (aOR 1.48; 95% CI 1.16–1.90, p< 0.01)
[17]. Evaluations of teen clubs have been scarce, and both
Malawi studies recommended age-specialized programming
for adolescents and argued that more prospective research is
required with higher methodological quality.
To date, the effectiveness of the teen clubs on adolescents’
ARTadherence has not been formally evaluated in Namibia.
+is paper reports on the effects of the teen club intervention
against standard care on ART adherence and virologic
suppression amongst adolescents at the clinic. Table 1 shows
services provided in standard care compared to the teen
club. +e main difference between standard care and the
teen club is that the teen club provides a group-based
psychosocial support platform, which meets outside of the
routine clinic visits schedule to share experiences, deliver
presentations, engage in educational activities, to keep the
adolescents engaged in care and on ART, and improve their
overall we-being.
2. Methods
2.1. Study Setting, Design, and Population. A retrospective
cohort study was conducted using medical records of HIV
positive adolescents between ages of 10 and 19 years re-
ceiving ART at a hospital-based paediatric HIV clinic in
Windhoek, Namibia. +e paediatric ART clinic is a spe-
cialized HIV clinic with dedicated staff for paediatric HIV
management, which includes a physician, nurses, counsel-
lors, and other support staff. +e study population was
stratified into two groups of adolescents attending the teen
club and adolescents who were receiving standard care.
Routine clinical records of the study population from 1 July
2015 to 30 June 2017 were reviewed. All adolescents between
the ages of 10 and 19 years attending the clinic between 1
July 2015 and 30 June 2017 as their initial enrolment site
were eligible for inclusion in the study. +ere were no
changes in the treatment guidelines or clinical intervention
during the study period.
2.2. Participants’ Selection. +e study sample was all in-
clusive of the study population. Figure 1 below shows that an
estimated 720 children and adolescents were receiving ART
at the clinic and 482 of them were aged between 10 and 19
years with 85 being members of the teen club. According to
the 2014 Namibian National ART Guidelines, the child HIV
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disclosure process should be initiated as early as 6 years to 10
years of age [18]. Once adolescents are aware that they are
HIV infected, they become eligible to enroll in the teen club,
and a clinician can facilitate enrolment of the child into the
teen club, in consultation with the caregiver of the child. To
standardize exposure to the service delivery model at the
specialized clinic, all adolescents transferred in from other
clinics were excluded from the study, including 7 in the teen
Table 1: Comparison of standard care and teen club care.
Model of care
Similarities between teen club and standard care
3 monthly clinical visits except in high viral load patients who may be enrolled in monthly adherence counselling
Adolescents should have full disclosure by age 10–12; disclosure can be delayed depending on the cognitive ability of the adolescent
Goal-related transition from paediatric/adolescent to adult HIV services
Routine viral load monitoring and targeted viral load monitoring for suspected treatment failure
Age-appropriate and developmentally appropriate adherence counselling
Lost to follow-up/defaulter tracking and tracing
HIV treatment literacy training of guardians and caregivers on treatment adherence, disclosure, and stigma issues
Age-appropriate psychosocial support includes individualized counselling on issues such as treatment failure counselling, opportunistic
infections, STIs, sexual and reproductive health, alcohol use and abuse, mental health, child protection, and other topics according to the
adolescents’ needs
Routine discussion with the child on their experience at school and future plans
Linkage to relevant stakeholders and social support mechanisms in the community
Additional considerations and support in teen clubs
Adolescents should have full disclosure; this is a prerequisite for enrolment into the teen club; adolescents can enroll once disclosed to
In addition to age-appropriate psychosocial support offered in standard care, the teen club
Meets once a month on a Friday or Saturday in “safe spaces” at the clinic
Share challenges, fears, experiences, and coping mechanisms during monthly meetings
Have special talks or presentation of ALHIV-related topics from subject matter experts
Have access to information, education, and communication materials such as videos and dramas/acts on adolescence and HIV and
have discussions thereafter
Occasionally participate in teen club retreats and trips where recreational activities and life stories are shared
Electronic patient monitoring system (ePMS) with all clients on ART at 
Intermediate Hospital Katutura Paediatric ART clinic (N ≈ 720)
Selected all adolescents (10–19 years) who were on ART at the clinic between 1 July 
2015 and 30 June 2017 (N = 482)
97 excluded adolescents who were 
transferred from other facilities to 
the clinic, 7 of them in Teen Club (also 
excluded)
Adolescents (10–19 years) who were initiated and on ART at the clinic between 1 July 
2015 and 30 June 2017 (N = 385)
Selected adolescents (10–19 years) attending 
Teen Club at the clinic between 1 July 2015 
and 30 June 2017 (N = 78)
Selected adolescents (10–19 years) in 
standard care at the clinic between 1 July 
2015 and 30 June 2017 (N = 307)
Figure 1: Flow chart of sampling process for the study.
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club. Any adolescent who attended at least one teen club
meeting was considered exposed to the intervention. Sixteen
[16] teen club meetings were held during the study period
with an average of 42 adolescents attending each meeting
and each adolescent attending an average of 5 meetings over
the 2-year period.
+e calculatedminimum total sample size using Epi-Info
was 272 participants, with 46 from the teen club stratum
(exposed) and 226 in the standard care stratum (unexposed).
Parameters used to calculate sample size include a power of
80%, an assumed 20% difference between the two groups,
with a 95% confidence interval, and an unexposed/exposed
ratio of 5.
2.3. Data Abstraction and Management. Patient demo-
graphics and visit details are completed routinely by
healthcare workers into individual Patient Care Booklets
(PCBs) during clinic visits. Patient information is then
entered into an electronic Patient Monitoring System
(ePMS) by data clerks. Patient data was extracted from the
electronic database into an Excel spreadsheet. Teen club
members sign in at every teen club meeting. +e teen club
register was reviewed to match adolescents on the ePMS and
the teen club members using the unique ART numbers
allocated as unique patient identifiers.
Patient Care Booklets for adolescents with incomplete
records in ePMSwere retrieved, and themissing information
was added to the Excel spreadsheet. Extracted data was saved
onto a password protected Excel file to ensure that the data
could not be altered. Data cleaning and preparation/coding
were done on the Excel file which was then exported into a
Stata16 file for further processing and analysis.
2.4. Variables. Adherence to ART was assessed through
patient self-reports and pill counts conducted by clinicians
during the 24-month study period. Clinicians ask the pa-
tients about the number of missed doses per month and
conduct a physical pill-count. Virologic suppression has
been used in several ART adherence studies as the standard
biomarker of adherence levels and evidence shows that it is a
reliable predictor of good adherence [19]. Once viral load
results are received from the laboratory, they are recorded in
the PCBs and subsequently entered on the ePMS. Missing
viral load results on the ePMS were extracted from the PCBs.
+e most important exposure variable assessed is the model
of care, with teen club members in the exposed group and
adolescents in standard care in the unexposed group. Other
predictor variables of interest that were collected included
demographic and clinical characteristics such as age, sex,
period on ART, current ART regimen type, and HIV dis-
closure status. While this paper focuses on viral load sup-
pression, measured at three data collection points from the
study start date (months 6, 12, and 18), we also analysed
documented adherence at 3 monthly intervals from study
start date and overall retention in care (attending clinic
visits) at 24 months from study start date, which has been
reported elsewhere [20].
2.5. StatisticalAnalyses. +e dataset in Excel was exported to
Stata for the data analysis, and the analysis was done using
the Stata statistical software, release 16, College Station, TX,
StataCorp LLC. +e data analysis included univariate ana-
lyses to describe demographic variables such as sex and age
distribution; clinical variables such as model of care, dis-
closure status, period on ART, and type of regimen; and
virologic suppression and adherence measured by clinicians.
Bivariate analysis was performed using the chi-square test to
determine the significance of associations between ART
adherence and virologic suppression and selected demo-
graphic and clinical variables. Cut-off for significance of
associations was set at p< 0.05. If the sample size was very
small in any cell (<5), Fisher’s exact test was used as an
alternative to the chi-square test. Relative risk was also
calculated for comparison of ART adherence and virologic
suppression levels between teen club members and ado-
lescents in standard care. Calculation of relative risk was
conducted using the Poisson regression with the glm
command in Stata. Multivariate modeling was also per-
formed to determine the relative risk adjusting for age and
sex, disclosure, and type of ART regimen.
+is study was approved by the Namibian Biomedical
Research Ethics Committee and Research Management
Committee based at the Ministry of Health and Social
Services (Ref: 18/3/3 FM) and the University of the Western
Cape Biomedical Research Ethics Committee (Ref: BM17/8/
14).
3. Results
A total of 482 adolescents aged between 10 and 19 years
attended the paediatric ART clinic during the 2-year study
period. All records of the adolescents were extracted from
the ePMS for the two-year period. Records of adolescents
who were transferred in from other facilities, who had in-
correctly entered demographic information, and who are
with missing files/PCBs were excluded from the final study
sample. A total 385 adolescents were eligible, 78 of them
being in the teen club. +e average age amongst adolescents
included in the study was 14 years and 51% were aged 10–14
years whilst 49% were aged 15–19 years. However, as pre-
sented in Table 2, the proportion of older adolescents in the
teen club was much higher than that of the older adolescents
in standard care (66.7% vs. 44.3%; p � 0.015), and the same is
true for the female adolescents enrolled in the teen club
compared to standard care (59% vs. 43.6%; p � 0.001). +e
average measured ART adherence by the clinicians during
clinical visits was 89% good (≥95%), 6% fair (85–94%), and
5% poor (<85%) amongst all the adolescents over the 2 years.
All the adolescents in the teen club had their HIV status
disclosed to them (a requirement for enrolment in the club),
compared to 94% of adolescents in standard care (p � 0.031)
(Table 1). +e median duration on ART among all par-
ticipating adolescents was 10.3 years (interquartile
range� 7.7–11.7), mean duration on ARTof 9.4 years, with a
minimum of 1 month and a maximum of 17.4 years on ART.
+ere was no significant difference between teen club
members and those in standard care on duration on ART
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(100% vs. 99% 12 months or more), type of ART regimen
(68% vs. 74% on first line), adherence at 3 months (95% vs.
90% good adherence), and retention status at 24 months
(91% vs. 90% retained in care).
Viral load suppression amongst the adolescents who
were included in the study at the Paediatric ART clinic was
on average at 87% (68% fully suppressed and 19% sup-
pressed) and 13% not suppressed for the 2-year study period.
Full suppression is defined as a viral load <40 copies/ml or
Target not Detected (TND), whilst individuals with a viral
load between 40 and 999 copies/ml are categorized as
suppressed. Figure 2 shows that a similar trend was observed
during the 2-year period, at 6-month, 12-month, and 18-
month clinic visits during the study period.
Table 3 shows that there was no sufficient evidence of a
statistically significant difference in viral load suppression
levels at 6 months, 12 months, and 18 months between teen
club members and adolescents in standard care. No sta-
tistically significant differences were observed in viral load
suppression levels between adolescents whose HIV status
was disclosed to and those who were not disclosed to at 5%
significance level. +ere was sufficient evidence of statisti-
cally significant differences in viral load suppression at 5%
significance level between the younger (10–14 years) ado-
lescents and older (15–19 years) adolescents at 6 months and
at 12 months, but there was no statistically significant dif-
ference at 18 months at 5% level. +ere was also sufficient
evidence of a statistically significant difference in viral load
suppression between adolescents on a first line ARTregimen
and those on second line at 6 months, at 12 months, and at
18 months. It is logical that the adolescents on first-line ART
regimens were more likely to be suppressed than those on a
second-line regimen since transition to a second-line regi-
men may be indicative of treatment failure.
Table 4 shows that, at 6 months’ and 12 months’ follow-
up, the adjusted relative risk was significant for age and the
type of ARTregimen, with younger adolescents and those on
a first-line regimen having better viral load suppression
levels than the older adolescents and adolescents on a
second-line ART regimen, respectively. +ere was some
evidence that older adolescents may be less likely to achieve
viral suppression at 6, 12, and 18 months although this effect
largely disappeared after adjusting for sex, disclosure, and
type regimen.+ere were no significant differences observed
according to sex or disclosure status of the adolescents.
At 18 months, the adjusted relative risk for all variables
showed no significant differences. After controlling for age,
sex, disclosure status, and type of ARTregimen, the model of
care did not significantly influence viral load suppression at
6 months (p � 0.927), 12 months (p � 0.324), and 18 months
(p � 0.506). Compared to the primary findings, our study
found no significant differences in the sensitivity analysis on
viral load suppression rates between teen club members and
adolescents in standard care by age groups at 6 months
(p � 0.819) and 12 months (p � 0.427).
4. Discussion
+e overall viral load suppression rates among the adoles-
cents included in the study were at 87%—which almost
reached the initial UNAIDS target of 90%. Considering that
this study also found the overall retention in care rates to be
approximately 90.1% at 24 months among all adolescents
included in the study, it is indeed encouraging as it holds
hope for achieving the 95-95-95 targets. Similar viral load
suppression levels among adolescents have been reported in
other studies in Africa and in the sub-Saharan Africa region.
In South Africa, viral load suppression rates were reported to
be 81% among adolescents using a cut-off of <400 copies/ml
to define HIV-1 viral suppression [21]. A literature review
conducted in 2016 showed wider variations in studies that
assessed viral load suppression rates among adolescents at 12
months after ART initiation, with viral load suppression
rates ranging from 27% to 89% in studies stratified by
duration on ARTand 28% to 87% in studies not stratified by
duration on ART [22]. +is points to a greater need for
adolescent-friendly HIV services in national programs to
breach the 90% virologic suppression goal initially set by
global programs.
+is study did not show any significant differences in
viral load suppression rates between teen club members and
adolescents who were receiving standard care. Overall, the
viral load suppression rates were relatively high among all
adolescents included in the study. Considering that the study
setting is a specialized paediatric HIV clinic, the quality of
HIV care and treatment outcomes would generally be
Table 2: Demographic and clinical characteristics of adolescent
participants on ART at Intermediate Hospital Katutura Paediatric
ART Clinic (N� 385).




Male 205 173 (56.4) 32 (41.0) 0.015∗
Female 180 134 (43.6) 46 (59.0)
Age group
10–14 years 197 171 (55.7) 26 (33.3) 0.001∗∗
15–19 years 188 136 (44.3) 52 (66.7)
Disclosure status (n� 372)
Disclosed 355 278 (94.2) 77 (100) 0.031∗
Not disclosed 17 17 (5.8) 0 (0)
ART regimen
First-line
regimen 279 226 (73.6) 53 (67.9) 0.318
Second-line
regimen 106 81 (26.4) 25 (32.1)
Duration on ART
<12 months 3 3 (1.0) 0 (0) 0.382
≥12 months 382 304 (99.0) 78 (100)
Adherence at 3 months
Good 350 276 (90) 74 (95) 0.277
Fair 18 17 (6) 1 (1)
Poor 15 3 (4) 12 (4)
Retention status at 24 months
In care 347 276 (89.9) 71 (91.0) 0.931
Lost to follow-up 22 18 (5.9) 4 (5.1)
Transfer out 16 13 (4.2) 3 (3.9)
∗Correlation is significant at 0.05 level (2-tailed). ∗∗Correlation is signif-
icant at 0.01 level (2-tailed).
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expected to be better than HIV care in an integrated primary
healthcare (PHC) facility where you may not have dedicated
specialized staff to manage paediatric HIV patients.+e 2015
Namibia Preliminary Report for Adolescents Assessment
reported viral load suppression rates of 74% and 70% among
adolescent girls and boys, respectively, and 73% and 63%
among 10–14 year and 15-19 year olds, respectively [14]. Our
study population consists mostly of adolescents who had
been receiving specialized HIV care for more than 12
months, with a median period on ART of 10.3 years. +is
points to mostly treatment-experienced adolescents, and it is
expected that generally viral load should reach undetectable
levels by 6 months of therapy in fully adherent clients [14].
+e meta-analysis done by Ferrand et al. reported on varied
published viral load suppression results among adolescents
and emphasized the need to report suppression rates
stratified by duration on ART and reporting of median
duration on ART so as to contextualize treatment outcomes
[22].
Another study in South Africa showed that there were
better viral suppression levels in an adolescent-friendly HIV
clinic (91%) compared to those in a standard paediatric
clinic (80%) [21]. However, the adolescent-friendly clinic
was based on a differentiated care model, providing HIV
medication, psychosocial and peer support, education and
sports, lunches, and other entertainment activities through a
Saturday clinic [21]. +e model for the adolescent-friendly
clinic reduced school absenteeism and stigma in addition to
the services provided, resulting in better viral suppression
levels and retention in care. Our study setting already
provided a high level of standard of care, with the teen club
only as an additional psychosocial support intervention,
which may have resulted in a limited impact of the teen club
intervention.
Our results suggest that the teen club intervention model
implemented at the specialized paediatric HIV clinic may
not offer adequate additional benefits to the club members
on viral suppression, which may depend on other factors
besides levels of adherence to treatment. Several reports have
also showed reduced viral suppression levels amongst older
adolescents and considering that most of the teen club
members in our study were older adolescents, age could have
influenced viral suppression levels among club members.
+e results showed that the teen club consists of twice as
many older adolescents compared to younger adolescents
and that the teen club had a higher proportion of older
adolescents as compared to the standard care arm.
+ere was a significant difference in viral load sup-
pression levels between older and younger adolescents, with
the older adolescents having less chance of viral load sup-
pression compared to younger adolescents, although this
difference was minimal and reduced after adjusting for sex,
disclosure, and ART regimen. Similar results have been
described in other studies in Africa, with Evans et al.
reporting that older adolescents were more likely to be
unsuppressed as compared to their younger counterparts at
6 months in a study conducted in adolescents and young
adults in Mpumalanga (RR� 1.75; 95% CI� 1.25–2.47) [23].
+e association between age and viral suppression was also
described as a significant factor in other studies that com-
pared viral suppression levels among young adults and
adolescents, showing that younger adolescents had higher
rates of viral load suppression [19, 20]. As discussed earlier,
the paediatric HIV clinics provide a more favourable en-
vironment for younger adolescents in general, and the
younger adolescent is more likely to have better treatment
outcomes due to closer caregiver support. +e Windhoek
teen club intervention model may need to strengthen the
efforts already underway to deliver content developmentally
tailored by age group.
Overall, the standard of care at the specialized paediatric
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Figure 2: Virologic suppression levels among adolescents on antiretroviral therapy by model of care.
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rates than reported elsewhere in Namibia. Indeed, as re-
ported elsewhere many HIV programs in low- and middle-
income countries may not have very strong standard of care
models for adolescents to achieve similar treatment out-
comes as the specialized paediatric clinic, as such the results
may not be generalizable. +erefore, more research on the
impact of group-based interventions such as teen clubs in
settings where there are no specialized services is needed.
5. Conclusions
+e teen club model delivering psychosocial support only
did not improve adherence and virologic suppression levels
for adolescents in a specialized paediatric ARTclinic, neither
were they inferior to standard care. Considering the limi-
tations of this study, teen clubs may still hold potential for
improving adherence and virologic suppression levels for
older adolescents, and more robust research on adherence
interventions for adolescents with higher methodological
quality is required.
6. Limitations to the Study
+e use of a retrospective cohort study design meant that we
had to rely on the accuracy of the record keeping by the
healthcare workers. Reliance on routinely collected data
meant that we could not control the exposures and outcomes
of interest and could not account for unmeasured factors
due to the limitations of routinely collected variables. +e
amount of missing data and files could have potentially
influenced the findings of the results. +e inequivalence in
sample sizes between the comparison groups (teen club
members vs. adolescents in standard care) could also po-
tentially result in a type II error. Another limitation is the
lack of detailed contents of each teen club session but just an
overall description of topics discussed in general. +is in-
formation could put some of the results into context and
facilitate discussions into modifying the intervention where
necessary. +e dose effect was also not thoroughly investi-
gated, as a single attendance to the teen club was considered
as exposure to the intervention.
Data Availability
+e data used to support the findings of this study are available
within the article.
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